Cargando…
Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats
BACKGROUND: Decrease of peroxisome proliferator-activated receptors-δ (PPARδ) expression has been observed after spinal cord injury (SCI). Increase of PPARδ may improve the damage in SCI. Telmisartan, the antihypertensive agent, has been mentioned to increase the expression of PPARδ. Thus, we are go...
Autores principales: | Lin, Chien-Min, Tsai, Jo-Ting, Chang, Chen Kuei, Cheng, Juei-Tang, Lin, Jia-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544623/ https://www.ncbi.nlm.nih.gov/pubmed/26316709 http://dx.doi.org/10.2147/DDDT.S86616 |
Ejemplares similares
-
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
por: Cheng, Kai-Chun, et al.
Publicado: (2018) -
Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury
por: Tsai, Cheng-Chia, et al.
Publicado: (2014) -
Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
por: Chang, Wei-Ting, et al.
Publicado: (2016) -
Exercise Preconditioning Protects against Spinal Cord Injury in Rats by Upregulating Neuronal and Astroglial Heat Shock Protein 72
por: Chang, Cheng-Kuei, et al.
Publicado: (2014) -
Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats
por: Lee, Chang Ho, et al.
Publicado: (2021)